Provided by Tiger Fintech (Singapore) Pte. Ltd.

TG Therapeutics

40.84
+3.7810.20%
Post-market: 41.000.1600+0.39%19:56 EDT
Volume:4.82M
Turnover:194.91M
Market Cap:6.41B
PE:-411.65
High:41.85
Open:37.50
Low:37.44
Close:37.06
Loading ...

Is TG Therapeutics, Inc. (TGTX) the Best Performing Growth Stock in 2025?

Insider Monkey
·
Yesterday

TG Therapeutics call volume above normal and directionally bullish

TIPRANKS
·
12 Mar

Biotech Stock TG Therapeutics Hits A High In Market Meltdown

Blockhead
·
11 Mar

TG Therapeutics (NasdaqCM:TGTX) Surges 28% Following US$23 Million Net Income Turnaround

Simply Wall St.
·
10 Mar

S&P 500 Pair, Warren Buffet Pick Lead Five Stocks Near Buy Points Amid Market Shakeout

Blockhead
·
09 Mar

Investing Action Plan: Inflation Data, Retail Earnings And The Secret Path To Drill, Baby, Drill

Blockhead
·
08 Mar

Why TG Therapeutics Stock Was Soaring This Week

Motley Fool
·
08 Mar

Stock Track | TG Therapeutics Surges 5% as Positive BRIUMVI Data Set for Presentation at AAN 2025

Stock Track
·
08 Mar

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

GlobeNewswire
·
07 Mar

This Biotech Stock Hits Buy Point After Earnings Burst

Blockhead
·
07 Mar

Stock Track | TG Therapeutics Soars 5% as BRIUMVI Propels Strong 2024 Results, Promising Pipeline Updates

Stock Track
·
04 Mar

TG Therapeutics Price Target Maintained With a $55.00/Share by HC Wainwright & Co.

Dow Jones
·
04 Mar

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.
·
04 Mar

Why TG Therapeutics, Inc. (TGTX) Surged On Monday?

Insider Monkey
·
04 Mar

TG Therapeutics Inc (TGTX) Q4 2024 Earnings Call Highlights: Strong U.S. ...

GuruFocus.com
·
04 Mar

Q4 2024 TG Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
04 Mar